Navigation Links
Speedus Engages Morgan Joseph to Evaluate Strategic Alternatives for Zargis Subsidiary
Date:2/3/2010

FREEHOLD, N.J., Feb. 3 /PRNewswire-FirstCall/ -- Speedus Corp. (Nasdaq: SPDE), announced today that it has engaged Morgan Joseph & Co. Inc., a full service investment bank, to evaluate strategic alternatives available to maximize shareholder value with respect to Speedus Corp's subsidiary, Zargis Medical Corp.  Zargis has created the world's first FDA-cleared medical software to identify and classify suspected systolic and diastolic heart murmurs and is the co-recipient of Popular Science magazine's 2009 "Innovation of the Year" award.

"We are very pleased to have Morgan Joseph serve as our financial advisor as we explore options to optimize the value of Zargis for Speedus shareholders.  Morgan Joseph is a leading middle market investment bank with expertise in the medical device and healthcare technology sectors," stated Shant Hovnanian, Chairman & CEO of Speedus.

According to Mitchell Stern, a Managing Director in Morgan Joseph's Healthcare Investment Banking Group, "Medical technology companies continue to attract interest, particularly when their technologies provide an opportunity to improve care while lowering systemic costs and offer applications for the home health and telemedicine markets.  Zargis is well-positioned for growth within all of these arenas. There's no question that it's a good time to explore opportunities for Zargis."

About Morgan Joseph & Co. Inc.

Morgan Joseph & Co. Inc. is a full service investment banking firm with over 120 employees in 11 offices dedicated to serving middle market companies. The firm's primary focus is on providing financial advisory and capital raising services in the U.S., Asia and Europe. Our services include mergers and acquisitions advice, restructuring advice, private placements and public offerings of debt and equity. For its institutional investor clients, Morgan Joseph provides a full range of sales and execution services, including equity research and specialized reports. For more information go to www.morganjoseph.com.

About Speedus Corp.

Speedus Corp. (NASDAQ: SPDE) operates through its two majority subsidiaries, Zargis Medical Corp. and Density Dynamics, Inc. Additional information on Speedus Corp. may be obtained at www.speedus.com or by contacting Peter Hodge at 888-773-3669 (ext. 23) or phodge@speedus.com.

FORWARD-LOOKING STATEMENTS

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, statements relating to the expected benefits of the Company's new relationship with Morgan Joseph & Co., Inc., including the effect of this relationship on the Company's future strategic plans, as well as statements that contain words such as "expect," "fully expect," "expected," "appears," "believe," "plan," "anticipate," "would," "goal," "potential," "potentially," "range," "pursuit," or "preliminarily." These forward-looking statements are subject to risks and uncertainties, including the risks and uncertainties that the Company's relationship with Morgan Joseph & Co, Inc., will not have the expected beneficial impact on the Company or on its future strategic goals, as well as the risks and uncertainties set forth in our Annual Report on Form 10-K filed October 13th, 2009, particularly those identified in Risk Factors Affecting Our Business. There can be no assurance that any expectation, express or implied, in a forward-looking statement will prove correct or that the contemplated event or result will occur as anticipated.

SOURCE Speedus Corp.

RELATED LINKS
http://www.speedus.com

'/>"/>

SOURCE Speedus Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Speedus Announces Compliance with Nasdaq Marketplace Rules 5250(c)(1) and 4350(b)(1)(B), and Receipt of Noncompliance Notification Related to Nasdaq Marketplace Rule 5550
2. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
3. Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives
4. Wound Management Technologies, Inc. Engages Miller Tabak, A National Investment Banking Firm Specializing in the Healthcare Market Space
5. Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference
6. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
7. Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
8. Lennox International to Present at J.P. Morgan Conference
9. Perrigo Company to Present at the 28th Annual J.P. Morgan Healthcare Conference
10. Amgen to Present at the 28th Annual JP Morgan Healthcare Conference
11. Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... , Isansys  Lifecare, a new generation ... Engine wireless patient monitoring platform, as it ships more systems ... , Scotland and Norway ... generation system, launched earlier this year, is now being used in ... , This new technology significantly enhances the user experience ...
(Date:5/31/2016)... 2016 194 Mitgliedsstaaten ... Eliminierung von viraler Hepatitis    Am ... eingegangen, virale Hepatitis bis 2030 zu eliminieren. ... Assembly haben sich die Staaten einstimmig dafür entschieden, ... Viral Hepatitis Strategy) zu verabschieden, was das bisher ...
(Date:5/31/2016)... May 31, 2016 RnRMarketResearch.com adds ... with comparative analysis of Asthma therapy at various stages, ... route of administration (RoA) and molecule type, along with ... also reviews key players involved in the therapeutic development ... projects. Complete report on H1 2016 pipeline ...
Breaking Medicine Technology:
(Date:5/31/2016)... ... May 31, 2016 , ... ... technology solutions to the healthcare industry, The University of Scranton is adding a ... accelerated path to a career in rapidly growing field of healthcare information. ...
(Date:5/30/2016)... ... ... As the CDC relaxes its stance on traditional No-Nit policies, parents wonder ... lice free. , According to a May 26 article from news source ... classroom despite the fact that they may be harboring an infestation. Previous No-Nit policies ...
(Date:5/30/2016)... , ... May 30, 2016 , ... ... 6th, while Shaolin warrior 8-day-8 and 8-night special intensive summer training camp starts ... annual overnight summer camp offers families and children a fun and unique experience ...
(Date:5/29/2016)... North Carolina (PRWEB) , ... May 29, 2016 , ... ... Now, via Amazon.com, their new KlipPro KP-240L clipper is available to the public. This ... which is substantially wider than the average clipper. , Everything about this product ...
(Date:5/28/2016)... ... ... "Color Grading media can be time consuming but with FCPX LUT Night ... Austin - CEO of Pixel Film Studios. , With the FCPX LUT Night ... to their footage. A LUT is a Lookup Table that contains a mathematical formula ...
Breaking Medicine News(10 mins):